Honeywell appoints Thermo Fisher CFO Stephen Williamson to board as independent director

HONEYWELL INTERNATIONAL INC

Stephen Williamson, 58, appointed independent director and Audit Committee member, effective April 1, 2025.
Williamson is current SVP and CFO of Thermo Fisher Scientific (since 2015); previously held Honeywell finance roles including VP/CFO Asia Pacific.
He will stand for election at 2025 Annual Meeting and receive standard non-employee director compensation.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Stephen Williamson

Independent Director

HON · HONEYWELL INTERNATIONAL INC

Effective: 2025-04-01
Filed: April 1, 2025, 7:59 PM ET

On April 1, 2025, Stephen Williamson, 58, Senior Vice President and Chief Financial Officer of Thermo Fisher Scientific Inc., was appointed to the Board of Directors of Honeywell International Inc. (the “Company”) as an independent director and member of the Audit Committee, effective April 1, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Stephen Williamson was appointed as Independent Director at HONEYWELL INTERNATIONAL INC.

Action: appointed
Role: Independent Director

Exact text from the filing

On April 1, 2025, Stephen Williamson, 58, Senior Vice President and Chief Financial Officer of Thermo Fisher Scientific Inc., was appointed to the Board of Directors of Honeywell International Inc. (the “Company”) as an independent director and member of the Audit Committee, effective April 1, 2025.

View on SEC.gov

HONEYWELL INTERNATIONAL INC filing history →

Source: SEC EDGAR

accession 0000773840-25-000019

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.